Once a fringe curiosity reserved for psychonauts and Silicon Valley biohackers, psychedelics are now flirting with the mainstream—only this time, it’s less about tripping and more about healing.

Nessa Yip sits down with Dr. Ayla Sela to discuss the possibilities of psychedelic medicine The classic psychedelics – LSD, psilocybin, DMT – are psychoactive compounds known to elicit a repertoire of ...

Chief executives and politicians are promoting the drugs for therapeutic use. Do you have questions about them? By the staff of The Morning Psychedelics have many famous fans. America’s health ...

Research is suggesting that consuming substances like ketamine and MDMA could make it easier to make lifestyle changes, but ...

Sept. 11, 2025 -- Psychedelics like ketamine, psilocybin, and MDMA are emerging as promising treatments for mood disorders that don’t respond to standard care. What has research shown using these ...

Researchers at the UC Davis Institute for Psychedelics and Neurotherapeutics are exploring the world of endogenous psychedelics while also creating a massive library of psychedelic compounds and ...

Texas passed a landmark law in June 2025, supported by former Gov. Rick Perry, that allocates US$50 million to support research on ibogaine, one of the most powerful psychedelics, for treating opioid ...

From Aha! moments to scientific discovery, learn how altered states can open cognitive space for new ideas—and why that matters now more than ever.

A new analysis of global pharmacovigilance data indicates that while reports of psychiatric distress are common among users ...

The increasing availability of legal psychedelic therapy programs, such as those in Colorado and Oregon, has led researchers to take a broader look into various aspects of how people use these ...

Months after Massachusetts voters rejected a ballot measure to legalize some psychedelics, a burst of newly filed bills has reignited debate on Beacon Hill. Just shy of 57% of voters in November said ...

Texas passed a landmark law in June 2025, supported by former Gov. Rick Perry, that allocates $50 million to support research on ibogaine, one of the most powerful psychedelics, for treating opioid ...